Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Qualigen Therapeutics Inc...

    NASDAQ: QLGN · Real-Time Price · USD
    1.90
    0.00 (0.00%)
    At close: Aug 19, 2025, 3:58 PM
    1.93
    1.58%
    After-hours: Aug 19, 2025, 05:58 PM EDT

    Qualigen Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 1.17M 401.8K 7.03M 17.54M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a 5.69K n/a
    Other Long-Term Assets
    		 2K 866.48K 24.02K 18.33K
    Receivables
    		 2.01M n/a 538.59K 822.35K
    Inventory
    		 n/a n/a 1.59M 1.06M
    Other Current Assets
    		 31.2K n/a 4.16M 3.58K
    Total Current Assets
    		 4.68M 1.17M 10.82M 20.8M
    Property-Plant & Equipment
    		 n/a n/a 1.77M 1.85M
    Goodwill & Intangibles
    		 n/a n/a 6.47M 171.19K
    Total Long-Term Assets
    		 2K 866.48K 8.26M 2.04M
    Total Assets
    		 4.69M 2.03M 19.08M 22.84M
    Account Payables
    		 1.57M 2.22M 619.57K 886.22K
    Deferred Revenue
    		 n/a n/a 116.16K 135.06K
    Short-Term Debt
    		 n/a 1.3M 60.2K 134.09K
    Other Current Liabilities
    		 269.18K 63.45K 7.18M 2.35M
    Total Current Liabilities
    		 2.01M 4.14M 8.61M 4.64M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a 1.3M n/a
    Total Long-Term Liabilities
    		 n/a n/a 1.71M 1.64M
    Total Liabilities
    		 2.01M 4.14M 10.32M 6.27M
    Total Debt
    		 n/a 1.3M 2.71M 1.68M
    Common Stock
    		 65.31K 43.26K 42.11K 35.29K
    Retained Earnings
    		 -123.06M -116.8M -103.39M -84.74M
    Comprehensive Income
    		 n/a n/a 50.72K n/a
    Shareholders Equity
    		 2.68M -2.1M 7.24M 16.56M
    Total Investments
    		 n/a n/a 5.69K n/a

    Add to Watchlist